Greek
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Effectiveness of Cinnamon on Insulin Resistance ( ECIRCCOS ) December 1, 2019

Μόνο εγγεγραμμένοι χρήστες μπορούν να μεταφράσουν άρθρα
Σύνδεση εγγραφή
Ο σύνδεσμος αποθηκεύεται στο πρόχειρο
ΚατάστασηΠρόσληψη
Χορηγοί
Coordinación de Investigación en Salud, Mexico
Συνεργάτες
Hospital Infantil de Mexico Federico Gomez

Λέξεις-κλειδιά

Αφηρημένη

Childhood obesity is one of the most serious public health problems of the 21st century. It is considered that if there are no changes in prevention and treatment strategies there will be an increase to 70 million obese children by 2025. Of the only pharmacological treatments accepted at this age to improve insulin resistance is metformin, but it can condition gastrointestinal, muscular and hepatic adverse events. Cinnamon is an alternative therapy, which due to its high concentrations of polyphenols, improves insulin resistance by decreasing the proinflammatory environment that occurs in this group of patients, and unlike metformin with less frequent adverse events. The effectiveness of cinnamon has been demonstrated by decreasing insulin resistance in the adult population.

Περιγραφή

Controlled clinical trial, 100 children aged 10 to 15 years with obesity Body Mass Index (BMI> 2 SD) will be selected. Children and parents who agree to participate will be measured anthropometry (weight, height, BMI, body fat) and Tanner stage. Once the 100 children have been selected and registered, a determination will be made after 8 hours of fasting leptin, ghrelin, insulin, lipid profile, liver function tests, creatinine and cinnamic acid. Subsequently they will be randomly assigned to a group that receives the intervention with cinnamon 3000mg / day, or placebo; Both groups will receive diet and physical activity recommendations according to the World Health Organization (WHO) guidelines. They will be followed for 16 weeks. During this period, patients will be contacted weekly to confirm the consumption of the capsules and interrogation of adverse effects such as dyspepsia, gastrointestinal disturbances and headache. They will be scheduled monthly for capsule counting and interrogation of adverse effects. At the end of the 16-week follow-up, anthropometry, fasting after 8 hours of leptin, ghrelin, insulin lipid profile, liver function tests, creatinine and cinnamic acid will be performed.

Statistical analysis: Shapiro Wilk test will be applied to the variables with quantitative measurement scale to identify the type of distribution; in the case of parametric distribution, the data with averages and standard deviation will be presented, in case of presenting non-parametric distribution, medium and minimum and maximum values will be used. In the case of qualitative variables, they will be expressed with percentages and simple frequencies. Baseline characteristics will be compared between the two groups with t-Student or U-Mann Whitney according to the type of distribution of the variables. To evaluate the effect of the intervention, body fat deltas and biochemical measurements will be calculated by subtracting the final value (after 16 weeks of intervention) from the initial (baseline) value and statistical significance will be evaluated using comparisons between groups with paired t- or Wilcoxon. Covariance analysis control of confounding variables (ANCOVA) will be carried out.

Ημερομηνίες

Τελευταία επαλήθευση: 06/30/2020
Πρώτα υποβλήθηκε: 11/11/2019
Υποβλήθηκε εκτιμώμενη εγγραφή: 07/13/2020
Δημοσιεύτηκε για πρώτη φορά: 07/16/2020
Υποβλήθηκε τελευταία ενημέρωση: 07/13/2020
Δημοσιεύτηκε η τελευταία ενημέρωση: 07/16/2020
Ημερομηνία έναρξης της πραγματικής μελέτης: 11/11/2019
Εκτιμώμενη κύρια ημερομηνία ολοκλήρωσης: 10/31/2020
Εκτιμώμενη ημερομηνία ολοκλήρωσης μελέτης: 11/30/2020

Κατάσταση ή ασθένεια

Obesity, Childhood
Insulin Resistance
Insulin Sensitivity

Παρέμβαση / θεραπεία

Dietary Supplement: Cinnamon

Φάση

-

Ομάδες βραχιόνων

ΜπράτσοΠαρέμβαση / θεραπεία
Experimental: Cinnamon
In this group, children will receive an intervention with 3000mg / day cinnamon along with diet and physical activity recommendations according to the WHO guidelines. They will be followed for 16 weeks. During this period, patients will be contacted weekly to corroborate the consumption of the capsules and interrogation of adverse effects such as dyspepsia, gastrointestinal disturbances and headache. They will be scheduled monthly for capsule counting and interrogation of adverse effects.
Dietary Supplement: Cinnamon
children recipe 3 grams by day of cinnamon
No Intervention: Control
In this group, children will receive a placebo intervention along with diet and physical activity recommendations according to the WHO guidelines. They will be followed for 16 weeks. During this period, patients will be contacted weekly to corroborate the consumption of the capsules and interrogation of adverse effects such as dyspepsia, gastrointestinal disturbances and headache. They will be scheduled monthly for capsule counting and interrogation of adverse effects.

Κριτήρια καταλληλότητας

Επιλέξιμες ηλικίες για μελέτη 10 Years Προς την 10 Years
Φύλα επιλέξιμα για μελέτηAll
Δέχεται υγιείς εθελοντέςΝαί
Κριτήρια

Inclusion Criteria:

- obesity (BMI > 95 percentile )

Exclusion Criteria:

- treatment with insulin or Metformin

- genetic or endocrine obesity

- routine consumption of cinnamon

Αποτέλεσμα

Πρωτεύοντα αποτελέσματα

1. homeostatic model assessment (HOMA) index [16 weeks]

resistence insulin is evaluated for fasting glucose and insulin

2. Appetite hormone (ghrelin [pg/ml]) [16 weeks]

Change in fasting serum ghrelin from baseline to the end of intervention

3. Appetite hormone (leptin [ng/ml]) [16 weeks]

Change in fasting serum leptin from baseline to the end of intervention

Δευτερεύοντα αποτελέσματα

1. Body mass index (BMI) [16 weeks]

change in BMI from baseline to the end of intervention

Γίνετε μέλος της σελίδας
μας στο facebook

Η πληρέστερη βάση δεδομένων φαρμακευτικών βοτάνων που υποστηρίζεται από την επιστήμη

  • Λειτουργεί σε 55 γλώσσες
  • Βοτανικές θεραπείες που υποστηρίζονται από την επιστήμη
  • Αναγνώριση βοτάνων με εικόνα
  • Διαδραστικός χάρτης GPS - ετικέτα βότανα στην τοποθεσία (σύντομα)
  • Διαβάστε επιστημονικές δημοσιεύσεις που σχετίζονται με την αναζήτησή σας
  • Αναζήτηση φαρμακευτικών βοτάνων με τα αποτελέσματά τους
  • Οργανώστε τα ενδιαφέροντά σας και μείνετε ενημερωμένοι με την έρευνα ειδήσεων, τις κλινικές δοκιμές και τα διπλώματα ευρεσιτεχνίας

Πληκτρολογήστε ένα σύμπτωμα ή μια ασθένεια και διαβάστε για βότανα που μπορεί να βοηθήσουν, πληκτρολογήστε ένα βότανο και δείτε ασθένειες και συμπτώματα κατά των οποίων χρησιμοποιείται.
* Όλες οι πληροφορίες βασίζονται σε δημοσιευμένη επιστημονική έρευνα

Google Play badgeApp Store badge